When treating osteosarcomas, treatment with DHA bFGF in samples O-P1 and O-P2 exerts a stronger influence on SOD1 expression compared to treatments with AA bFGF, while in Ch-P4, L-P5, and Rm-P6, the effect was the opposite. This evidence concerns the gene SOD1 and osteosarcoma.